Our study reveals that HIF-1α and TGF-β1 cooperatively regulate pancreatic cancer ECM remodeling through direct interaction and Smad signaling, providing a foundation for therapeutic strategies targeting this axis. Here, HIF1A is linked to familial pancreatic carcinoma.